Capture NASA Medical Robotics Integration Standard via Sovereignty Legal Choke-Point

Intel / Context Summary

NASA holds nearly 50 patented and patent-pending technologies from the Robonaut 2 program specifically positioned for medical applications, with established licensing infrastructure but zero documented market demand signals. The agency has supply-side readiness through its Technology Transfer Program but lacks commercial validation and market pull evidence.

Catalyst: Why Now

NASA has world-class robotics IP but lacks commercial market access and integration frameworks, creating a void for establishing proprietary interface standards that become mandatory for medical device integration.

Friction: The Bottleneck

• Vulnerability: NASA has world-class robotics IP but lacks commercial market access and integration frameworks, creating a void for establishing proprietary interface standards that become mandatory for medical device integration.
• Capital yield: $125k initial licensing fees (5 companies × $25k) + 3% royalty stream on $50M+ device sales
• Resource capture: Exclusive integration framework IP and mandatory interface standard for NASA robotics in medical applications
• Influence capture: De facto standards authority for space-grade robotics in medical devices
• Sovereignty yield: Legal choke-point controlling access between NASA IP and medical device market
• Required vectors: Vector: Intellectual Property Law, Vector: Corporate Finance, Vector: Medical Device Regulatory, Vector: Technical Documentation

Wedge: Execution Protocol

Phase 1: Patent Portfolio Intelligence & Licensing Terms Discovery: Submit FOIA request to NASA Office of Inspector General for all Robonaut 2 patent licensing agreements executed in the last 5 years, including royalty rates, exclusivity terms, and licensee identities. Simultaneously, scrape USPTO assignment database for all patents under MSC-TOPS-45 to identify expiration dates and current status. → Phase 2: Establish Integration Standard & Form SPV Entity: Draft 'NASA Medical Robotics Integration Protocol v1.0' document establishing proprietary interface standards for connecting NASA's manipulation systems to medical device controllers. Form Delaware C-Corp with $50k capital injection to serve as licensing SPV. File provisional patent for the integration framework. → Phase 3: Secure Exclusive Licensing Option from NASA: Submit ATLAS application for exclusive medical applications license for 10 core manipulation patents identified in Phase 1. Negotiate with Leonard Yowell's team using FOIA-obtained pricing data as leverage. Structure deal as exclusive option with 12-month development window and minimum royalty guarantee. → Phase 4: Monetize Through Mandatory Integration Licensing: Target 50 medical device companies from FDA 510(k) database for robotic surgical devices. Send cold outreach with integration protocol and licensing terms: $25k integration license fee + 3% royalty on devices using NASA IP. Require all licensees to adopt the proprietary interface standard.

Routing Vectors

Specific Roles Required

Claim Protocol